Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 1
1918 1
1920 1
1923 1
1927 1
1931 1
1976 1
1977 1
1979 1
1980 1
1981 2
1982 2
1984 1
1985 5
1987 4
1988 2
1989 1
1991 6
1992 3
1993 5
1994 6
1995 3
1996 2
1997 3
1998 1
1999 1
2000 3
2001 8
2002 2
2003 3
2004 9
2005 4
2006 6
2007 4
2008 2
2009 1
2010 1
2013 2
2014 4
2015 1
2017 3
2018 5
2020 6
2021 4
2022 5
2023 5
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Undergraduate ophthalmology teaching.
O'Day J. O'Day J. Aust N Z J Ophthalmol. 1992 Nov;20(4):277. doi: 10.1111/j.1442-9071.1992.tb00738.x. Aust N Z J Ophthalmol. 1992. PMID: 1295521 No abstract available.
The Cal-DSH diversion guidelines.
Cummings MA, Scott C, Arguello JC, Arias AW, Breth AM, Delgado D, Harvey PD, Meyer JM, O'Day J, Pollock M, Proctor G, Rector T, Rose B, Schwartz E, Thordarson H, Warburton K, Stahl SM. Cummings MA, et al. Among authors: o day j. CNS Spectr. 2020 Oct;25(5):701-713. doi: 10.1017/S1092852920001819. CNS Spectr. 2020. PMID: 33111661 Review.
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
Keech AC, Mitchell P, Summanen PA, O'Day J, Davis TM, Moffitt MS, Taskinen MR, Simes RJ, Tse D, Williamson E, Merrifield A, Laatikainen LT, d'Emden MC, Crimet DC, O'Connell RL, Colman PG; FIELD study investigators. Keech AC, et al. Among authors: o day j. Lancet. 2007 Nov 17;370(9600):1687-97. doi: 10.1016/S0140-6736(07)61607-9. Epub 2007 Nov 7. Lancet. 2007. PMID: 17988728 Clinical Trial.
Horner syndrome.
Kong YX, Wright G, Pesudovs K, O'Day J, Wainer Z, Weisinger HS. Kong YX, et al. Among authors: o day j. Clin Exp Optom. 2007 Sep;90(5):336-44. doi: 10.1111/j.1444-0938.2007.00177.x. Clin Exp Optom. 2007. PMID: 17697179 Free article.
Horse riding: a dangerous sport.
O'Day J. O'Day J. Clin Exp Ophthalmol. 2001 Aug;29(4):207. doi: 10.1046/j.1442-9071.2001.00415.x. Clin Exp Ophthalmol. 2001. PMID: 11545415 No abstract available.
Uveal effusion syndrome.
Stelmach MZ, O'Day J, Ryan H. Stelmach MZ, et al. Among authors: o day j. Aust N Z J Ophthalmol. 1994 May;22(2):139-43. doi: 10.1111/j.1442-9071.1994.tb00782.x. Aust N Z J Ophthalmol. 1994. PMID: 7917269
“Meta-guidelines” for the management of patients with schizophrenia.
Stahl SM, Morrissette DA, Citrome L, Saklad SR, Cummings MA, Meyer JM, O'Day JA, Dardashti LJ, Warburton KD. Stahl SM, et al. Among authors: o day ja. CNS Spectr. 2013 Jun;18(3):150-162. doi: 10.1017/S109285291300014X. CNS Spectr. 2013. PMID: 23591126 Review.
Use of botulinum toxin in neuro-ophthalmology.
O'Day J. O'Day J. Curr Opin Ophthalmol. 2001 Dec;12(6):419-22. doi: 10.1097/00055735-200112000-00006. Curr Opin Ophthalmol. 2001. PMID: 11734681 Review.
131 results